Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
Mol Imaging Biol
.
2022 Jun;24(3):510.
doi: 10.1007/s11307-022-01709-1.
Authors
Ida Friberger
1
,
Emma Jussing
2
3
,
Jinming Han
1
4
,
Jeroen A C M Goos
1
2
3
,
Jonathan Siikanen
2
5
,
Helen Kaipe
6
7
,
Mélanie Lambert
8
,
Robert A Harris
1
4
,
Erik Samén
2
3
,
Mattias Carlsten
7
8
,
Staffan Holmin
1
9
,
Thuy A Tran
10
11
12
Affiliations
1
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
2
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
3
Department of Radiopharmacy, Karolinska University Hospital, Stockholm, Sweden.
4
Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
5
Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.
6
Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
7
Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
8
Center for Cell Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Stockholm, Sweden.
9
Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden.
10
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
[email protected]
.
11
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
[email protected]
.
12
Department of Radiopharmacy, Karolinska University Hospital, Stockholm, Sweden.
[email protected]
.
PMID:
35174429
PMCID:
PMC9085663
DOI:
10.1007/s11307-022-01709-1
No abstract available
Publication types
Published Erratum